Goodrx Holdings Inc Cl A (GDRX)

Jan 13, 2025, 6:00 PM EST - 4 days ago

GoodRx CFO Karsten Voermann to Resign for Personal Reasons

Jan 10, 2025, 11:00 AM EST - 7 days ago

GoodRx Offering Free Telehealth Appointments to Los Angeles Residents Affected by Wildfires

Jan 7, 2025, 9:00 AM EST - 10 days ago

GoodRx Unleashes “GoodRx for Pets,” Simplifying Access and Reducing Costs for Pet Medications

Dec 24, 2024, 8:00 AM EST - 24 days ago

Digital health companies got pummeled by Wall Street in 2024 as industry adapts to post-Covid slowdown

DOCS DXCM HIMS ME OSCR PGNY TDOC

Dec 18, 2024, 4:05 PM EST - 4 weeks ago

GoodRx to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Dec 17, 2024, 9:00 AM EST - 4 weeks ago

GoodRx Report Shows Millions at Risk as Endocrinologist Shortages Hit Nearly 70% of U.S. Counties

Dec 16, 2024, 4:05 PM EST - 4 weeks ago

GoodRx Appoints Healthcare Industry Veteran, Wendy Barnes, as New Chief Executive Officer

Dec 5, 2024, 9:00 AM EST - 6 weeks ago

Prescription fills for weight loss drugs Zepbound and Wegovy more than doubled in 2024, GoodRx says

Dec 5, 2024, 9:00 AM EST - 6 weeks ago

GoodRx Reveals Americans Overspent on Weight Loss Medications by $200 Million This Year, Fills Still Surged

Nov 18, 2024, 9:00 AM EST - 2 months ago

GoodRx Helps Announces Recipients of 2024 Students for Healthcare Equity Scholarship

Nov 13, 2024, 12:38 PM EST - 2 months ago

Kuehn Law Encourages Investors of GoodRx Holdings, Inc. to Contact Law Firm

Nov 13, 2024, 7:00 AM EST - 2 months ago

Harrow Launches Access and Affordability Program with Price Reductions for Branded Products

HROW

Nov 7, 2024, 2:14 PM EST - 2 months ago

GoodRx Holdings, Inc. (GDRX) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 6:05 AM EST - 2 months ago

GoodRx Reports Third Quarter 2024 Results

Nov 5, 2024, 3:44 PM EST - 2 months ago

GoodRx and CVS Sued for Suppressing Pharmacy Reimbursement

CVS

Nov 4, 2024, 4:05 PM EST - 2 months ago

GoodRx to Participate in Upcoming Investor Conferences

Oct 31, 2024, 9:00 AM EDT - 2 months ago

GoodRx Unveils New E-commerce Platform, Launches with Opill®

Oct 29, 2024, 9:00 AM EDT - 2 months ago

GoodRx Announces Exclusive Low Cash Price for QSYMIA®, the Leading Branded Once-Daily Oral Weight Management Medication for Adults

Oct 28, 2024, 8:00 AM EDT - 2 months ago

Ronald E. Bruehlman Joins GoodRx Board of Directors

Oct 23, 2024, 9:00 AM EDT - 3 months ago

GoodRx Announces New Affordability Programs for Menopause Hormone Therapies

Oct 16, 2024, 9:00 AM EDT - 3 months ago

GoodRx Partnering with Retail Pharmacies to Deliver Pay-Over-Time Option Directly to Consumers

Oct 10, 2024, 5:41 PM EDT - 3 months ago

GoodRx Announces Date for Third Quarter 2024 Earnings Release and Conference Call

Oct 8, 2024, 2:46 PM EDT - 3 months ago

GoodRx Holdings: Failing To Gain Much Traction

Sep 26, 2024, 9:00 AM EDT - 4 months ago

GoodRx Announces Lowest Discounted Cash Price at Retail Pharmacy Locations for neffy® (epinephrine nasal spray)

Aug 8, 2024, 4:01 PM EDT - 5 months ago

GoodRX Subscription Revenue Down 8% but Active User Numbers Are Up

Aug 8, 2024, 1:07 PM EDT - 5 months ago

GoodRx Holdings, Inc. (GDRX) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 12:04 PM EDT - 5 months ago

GoodRx Reports Q2 Earnings With Increased Prescription Revenue But Subscription Challenges

Aug 8, 2024, 6:05 AM EDT - 5 months ago

GoodRx Reports Second Quarter 2024 Results

Jul 31, 2024, 3:44 AM EDT - 6 months ago

GoodRx Q2 Earnings Preview

Jul 18, 2024, 10:46 AM EDT - 6 months ago

Boehringer-GoodRx partner to offer Humira rival at 92% discount

Jul 18, 2024, 6:00 AM EDT - 6 months ago

Boehringer Ingelheim and GoodRx announce exclusive patient affordability initiative for Adalimumab-adbm injection, Boehringer's biosimilar to Humira®

Jul 11, 2024, 9:00 AM EDT - 6 months ago

GoodRx Announces Date for Second Quarter 2024 Earnings Release and Conference Call

Jul 10, 2024, 9:00 AM EDT - 6 months ago

Ian T. Clark Joins GoodRx Board of Directors

Jun 27, 2024, 4:58 PM EDT - 7 months ago

Drug prices have risen almost 40% over the last decade, according to a new tracker

Jun 26, 2024, 4:57 PM EDT - 7 months ago

GoodRx Debuts Tracker to Monitor Out-of-Pocket Prescription Costs

Jun 26, 2024, 9:00 AM EDT - 7 months ago

GoodRx Launches New “Prescription Cost Tracker” to Spotlight Key Factors Driving Out-of-Pocket Medication Costs in the U.S.

Jun 21, 2024, 11:20 AM EDT - 7 months ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of GoodRx

Jun 21, 2024, 11:00 AM EDT - 7 months ago

Investors With Losses In GoodRx Holdings Inc Are Encouraged By The Schall Law Firm To Make Contact Before The Deadline

Jun 21, 2024, 8:15 AM EDT - 7 months ago

GoodRx Holdings, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - GDRX

Jun 20, 2024, 11:00 AM EDT - 7 months ago

The Schall Law Firm Encourages Investors Who Have Suffered Losses With GoodRx Holdings Inc To Make Contact Before The Deadline

Jun 20, 2024, 5:45 AM EDT - 7 months ago

GoodRx Holdings, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before June 21, 2024 to Discuss Your Rights - GDRX

Jun 19, 2024, 11:00 AM EDT - 7 months ago

Investors With Losses In GoodRx Holdings Inc Are Encouraged By The Schall Law Firm To Make Contact Prior To The Deadline

Jun 18, 2024, 1:15 PM EDT - 7 months ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of June 21, 2024 in GoodRx Lawsuit – GDRX

Jun 18, 2024, 11:00 AM EDT - 7 months ago

The Schall Law Firm Encourages Investors Who Have Suffered Losses In GoodRx Holdings Inc To Make Contact Before The Deadline